Table 1 Baseline characteristics of the study population
β-Blocker therapy | Revascularization | |
|---|---|---|
(n = 20) | (n = 12) | |
Age (yrs) | 67 ± 8 | 68 ± 6 |
Gender (male/female) | 20/0 | 11/1 |
Time to follow-up (months) | 8 ± 3 | 9 ± 4 |
Nr of stenosed (> 70%) coronary arteries | 2.7 ± 0.5 | 2.5 ± 0.5 |
Nr of segments with contractile reserve | 5.5 ± 3.2 | 3.7 ± 1.7 |
NYHA classification | 2.3 ± 0.5 | 2.2 ± 0.5 |
Medication: | ||
Asperin | 95% | 100% |
Angiotensin converting enzyme inhibitors | 65% | 58% |
Diuretics | 55% | 50% |
Nitrates | 35% | 50% |
Nr of segments with: | ||
Dysfunctional tissue | 7.4 ± 3.2 | 5.5 ± 1.5 |
Adjacent tissue | 6.3 ± 2.0 | 6.5 ± 1.1 |
Remote tissue | 3.4 ± 2.6 | 5.1 ± 2.0 |